Jiangsu Cancer Institute & Hospital

This study is testing if a three-part treatment is better than standard chemotherapy for people with a type of stomach or esophagus cancer that can be removed with surgery. Before surgery, patients will get either standard chemotherapy alone or chemotherapy plus low-dose radiatio…

This study is testing whether adding two new immunotherapy drugs to standard chemotherapy (or to a different chemotherapy plus another targeted drug) can better shrink advanced ovarian tumors before surgery. The goal is to see if this approach helps more patients become eligible …

This study is testing a new combination of four drugs as the first treatment for advanced colorectal cancer that cannot be removed by surgery. It will enroll 70 patients who have not had prior cancer drug treatment. The main goal is to see how well the tumors shrink and how long …

This study is testing whether a three-part treatment given before surgery can better eliminate cancer cells in patients with operable non-small cell lung cancer. The treatment combines a short, precise course of radiation (SBRT) with two immunotherapy drugs and standard chemother…

This study aims to discover molecular markers in the blood and tumor tissue of patients with nasopharyngeal cancer. Researchers will collect samples from 60 patients before, during, and after their standard chemotherapy and radiation treatment. The goal is to find biological clue…